Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping Xiong

Showing results (471-480 of 484) with videos related to

Pageof 49
Sort By:
Frontiers in Pharmacology|March 17, 2023
The self-medication behaviors of residents and the factors related to the consideration of drug efficacy and safety-A cross-sectional study in ChinaPu Ge, Zi-Wei Zhang, Jin-Zi Zhang, et al.
Plos Medicine|July 30, 2020
Neonatal outcome in 29 pregnant women with COVID-19: A retrospective study in Wuhan, ChinaYan-Ting Wu, Jun Liu, Jing-Jing Xu, et al.
Cancer|June 23, 2017
Efficacy and safety of recombinant human lymphotoxin-α derivative with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-label, controlled, phase 2b trialFeng-Hua Wang, Yun Wang, Guo-Ping Sun, et al.
Cancer Immunology, Immunotherapy : CII|October 20, 2021
Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II studyJin-Ji Yang, Cheng Huang, Yun Fan, et al.
Journal of the National Cancer Institute|December 22, 2005
In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysisLi-E Wang, Ping Xiong, Sara S Strom, et al.
BMC Pregnancy and Childbirth|September 6, 2023
Effect of noninvasive embryo viability testing versus conventional IVF on the live birth rate in IVF/ICSI patients: a study protocol for a double-blind, multicenter, randomized controlled trialYan-Fei Cheng, Cui-Lian Zhang, Yun Liu, et al.
Chinese Journal of Cancer|December 24, 2017
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trialRui-Hua Xu, Lin Shen, Ke-Ming Wang, et al.
Molecular Ecology Resources|February 10, 2018
Draft genome sequence of ramie, Boehmeria nivea (L.) GaudichMing-Bao Luan, Jian-Bo Jian, Ping Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2023
Clinicopathologic features, tumor immune microenvironment and genomic landscape of EBV-related and EBV-unrelated poorly differentiated nonkeratinizing squamous cell carcinoma of the thymusYi-Jun Zhang, Si-Ping Xiong, Yuan-Zhong Yang, et al.
Archives of Medical Science : AMS|October 3, 2014
A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung cancersKe-Jun Liu, Zhong-Zhen Guan, Ying Liang, et al.
Pageof 49

Showing results (471-480 of 484) with videos related to

Sort By:
Pageof 49
Frontiers in Pharmacology|March 17, 2023
The self-medication behaviors of residents and the factors related to the consideration of drug efficacy and safety-A cross-sectional study in ChinaPu Ge, Zi-Wei Zhang, Jin-Zi Zhang, et al.
Plos Medicine|July 30, 2020
Neonatal outcome in 29 pregnant women with COVID-19: A retrospective study in Wuhan, ChinaYan-Ting Wu, Jun Liu, Jing-Jing Xu, et al.
Cancer|June 23, 2017
Efficacy and safety of recombinant human lymphotoxin-α derivative with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-label, controlled, phase 2b trialFeng-Hua Wang, Yun Wang, Guo-Ping Sun, et al.
Cancer Immunology, Immunotherapy : CII|October 20, 2021
Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II studyJin-Ji Yang, Cheng Huang, Yun Fan, et al.
Journal of the National Cancer Institute|December 22, 2005
In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysisLi-E Wang, Ping Xiong, Sara S Strom, et al.
BMC Pregnancy and Childbirth|September 6, 2023
Effect of noninvasive embryo viability testing versus conventional IVF on the live birth rate in IVF/ICSI patients: a study protocol for a double-blind, multicenter, randomized controlled trialYan-Fei Cheng, Cui-Lian Zhang, Yun Liu, et al.
Chinese Journal of Cancer|December 24, 2017
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trialRui-Hua Xu, Lin Shen, Ke-Ming Wang, et al.
Molecular Ecology Resources|February 10, 2018
Draft genome sequence of ramie, Boehmeria nivea (L.) GaudichMing-Bao Luan, Jian-Bo Jian, Ping Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2023
Clinicopathologic features, tumor immune microenvironment and genomic landscape of EBV-related and EBV-unrelated poorly differentiated nonkeratinizing squamous cell carcinoma of the thymusYi-Jun Zhang, Si-Ping Xiong, Yuan-Zhong Yang, et al.
Archives of Medical Science : AMS|October 3, 2014
A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung cancersKe-Jun Liu, Zhong-Zhen Guan, Ying Liang, et al.
Pageof 49